Cecilia Augustsson

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Pulmonary Embolism

Systemic Lupus Erythematosus

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Clinical case reports

Journal of clinical laboratory analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Cecilia Augustsson, Knut Taxbro, Karin Strandberg, Eva Zetterberg
A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma. Clinical case reports 12 (1) (2024)
Cecilia Augustsson, Karin Strandberg, Marianne Kjalke
Minimal interference of concizumab with standard clinical coagulation laboratory assays - An in vitro study. Haemophilia : the official journal of the World Federation of Hemophilia 30 (4) (2024)
Cecilia Augustsson, Karin Strandberg, Marianne Kjalke
Minimal interference of concizumab with standard clinical coagulation laboratory assays - An in vitro study. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Cecilia Augustsson, Knut Taxbro, Karin Strandberg, Eva Zetterberg
A nonneutralizing antibody as cause of prothrombin deficiency in a patient with follicular lymphoma. Clinical case reports 12 (1) (2024)
Karin Strandberg, Cecilia Augustsson
Evaluation of the Atellica COAG 360 coagulation analyzer in a specialized coagulation laboratory. Journal of clinical laboratory analysis 36 (3) (2022)
Myriam Martin, Cecilia Augustsson, Vivian Lind, Riam Al-Sabti, My Chi Lam, Nadine G Andersson, Karin Strandberg
Methods for anti-factor VIII antibody levels in haemophilia A patients - validation of a multiplex immunoassay and comparability with assays measuring non-neutralising and neutralising antibodies (inhibitors). Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Cecilia Augustsson, Eva Norström, Vivian Lind, Myriam Martin, Jan Astermark, Karin Strandberg
Validation of factor VIII activity for monitoring standard and extended half-life products and correlation to thrombin generation assays. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)